Furthermore, 77.8% of thymomas could be predicted as they expressed BAP1 and mTAP, showed no or low (<10%) expression of CD117, and contained clusters of thymocytes, a combination that was not observed in any of the thymic carcinomas. The gene discussed is MTAP; the disease is thymoma.